Teva Pharmaceutical Inds

ISIN US8816242098

 | 

WKN 883035

Market cap (in EUR)
27,032 m
Country
Israel
Sector
Healthcare
Dividend yield
0.00%
 

Overview

Quote

Description

Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. It operates through the following geographical segments: United States, Europe, and International Markets. The United States segment focuses on therapeutic area of central nervous system (CNS) portfolio, and is involved in the distribution business of generic, biosimilar and medicines, and over-the-counter (OTC) pharmaceutical products from the firm and third-party manufacturers to independent retail pharmacies, pharmacy retail chains, hospitals, and physician offices in the United States. The Europe segment offers OTC portfolio including SUDOCREM, NasenDuo, DICLOX FORTE, OLFEN Max, and FLEGAMINA brands in European Union, the United Kingdom, and certain other European countries. The International Markets segment provides its products to countries such as Canada, Israel, Russia, Latin America, and Japan. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.
Show more Show less
Healthcare Biopharmaceuticals Other Biopharmaceuticals Israel

Chart

Financials

Key metrics

Market capitalisation, EUR 27,032 m
EPS, EUR 0.55
P/B ratio 4.4
P/E ratio 45.4
Dividend yield 0.00%

Income statement (2024)

Revenue, EUR 15,336 m
Net income, EUR -1,522 m
Profit margin -9.93%

What ETF is Teva Pharmaceutical Inds in?

There are 22 ETFs which contain Teva Pharmaceutical Inds. All of these ETFs are listed in the table below. The ETF with the largest weighting of Teva Pharmaceutical Inds is the iShares Edge MSCI World Value Factor UCITS ETF USD (Dist).
ETF Weight Investment focus Fund size (in m EUR)
UBS Core MSCI World UCITS ETF USD acc 0.03%
Equity
World
4,695
iShares MSCI World UCITS ETF (Dist) 0.03%
Equity
World
7,468
Vanguard LifeStrategy 80% Equity UCITS ETF (EUR) Accumulating 0.00%
Equity
World
Multi-Asset Strategy
855
iShares MSCI World Health Care Sector Advanced UCITS ETF USD (Dist) 0.08%
Equity
World
Health Care
Social/Environmental
438
Vanguard LifeStrategy 20% Equity UCITS ETF Distributing 0.00%
Equity
World
Multi-Asset Strategy
14
Amundi Core MSCI World UCITS ETF USD Dist 0.03%
Equity
World
820
iShares MSCI ACWI UCITS ETF USD (Acc) 0.02%
Equity
World
20,831
Vanguard LifeStrategy 80% Equity UCITS ETF Distributing 0.00%
Equity
World
Multi-Asset Strategy
63
iShares Edge MSCI World Value Factor UCITS ETF USD (Dist) 0.21%
Equity
World
Value
168
Vanguard LifeStrategy 40% Equity UCITS ETF Accumulating 0.00%
Equity
World
Multi-Asset Strategy
187
Vanguard LifeStrategy 60% Equity UCITS ETF Accumulating 0.00%
Equity
World
Multi-Asset Strategy
640
UBS Core MSCI World UCITS ETF hEUR acc 0.03%
Equity
World
274
Xtrackers MSCI World UCITS ETF 1D 0.04%
Equity
World
4,440
Vanguard FTSE All-World UCITS ETF (USD) Accumulating 0.00%
Equity
World
25,806
iShares MSCI World ESG Enhanced CTB UCITS ETF USD (Dist) 0.00%
Equity
World
Social/Environmental
937
UBS Core MSCI World UCITS ETF USD dis 0.03%
Equity
World
1,204
iShares MSCI World Screened UCITS ETF USD (Dist) 0.03%
Equity
World
Social/Environmental
819
UBS Core MSCI World UCITS ETF hGBP dis 0.03%
Equity
World
91
Vanguard LifeStrategy 40% Equity UCITS ETF Distributing 0.00%
Equity
World
Multi-Asset Strategy
34
Vanguard LifeStrategy 60% Equity UCITS ETF Distributing 0.00%
Equity
World
Multi-Asset Strategy
86
Vanguard FTSE All-World UCITS ETF (USD) Distributing 0.00%
Equity
World
18,590
Vanguard LifeStrategy 20% Equity UCITS ETF Accumulating 0.00%
Equity
World
Multi-Asset Strategy
84

Performance

Returns overview

YTD +14.19%
1 month +37.69%
3 months +54.89%
6 months +59.93%
1 year +45.01%
3 years +198.66%
5 years +190.53%
Since inception (MAX) -52.29%
2024 +130.93%
2023 +7.26%
2022 +16.51%
2021 -4.49%

Monthly returns in a heat map

Risk

Risk metrics in this section:
 
  • Volatility, annualised, measured for 1, 3 and 5 year periods. The annualised volatility reflects the degree of price fluctuations during a one year period. The higher the volatility, the more significantly the price of the asset (stock, ETF, etc.) has changed in the past. Assets with higher volatility are generally considered more risky. We calculate the volatility based on the data for the past 1, 3 and 5 years so that you can see if price fluctuations for the ETF became stronger or weaker over time.
  • Return per risk for 1, 3 and 5 year periods. This is the annualised (i.e. converted to a one year period) past return divided by the past annualised volatility. The metric puts the historical return of an asset in relation to its historical risk and gives you a retrospective indication of the degree of price fluctuation you had to bear with in order to obtain the return. We calculate this parameter for 1, 3 and 5 year periods to display its evolution over time.
  • Maximum drawdown for a period. This shows the worst possible loss an investor could have suffered during the respective period, by first buying and subsequently selling the asset at the least favourable prices. For example, if there was the following sequence of daily ETF prices: 10€, 5€, 12€, 20€, an investor would have suffered the worst loss by buying for 10€ and subsequently selling for 5€. Therefore in this case the maximum drawdown would be (5€ - 10€)/10€ = -50%.
ETF returns include dividend payments (if applicable).
Show more Show less

Risk overview

Volatility 1 year 52.52%
Volatility 3 years 41.63%
Volatility 5 years 42.41%
Return per risk 1 year 0.86
Return per risk 3 years 1.06
Return per risk 5 years 0.56
Maximum drawdown 1 year -47.37%
Maximum drawdown 3 years -47.37%
Maximum drawdown 5 years -47.37%
Maximum drawdown since inception -91.56%

Rolling 1 year volatility

— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.

Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.